Statin lowers CV risk, in absence of LDL-c measurement
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Ulrich Laufs, MD, PhD
- MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
0.75 program creditsJulia Brandts, MD
- MinuteCE®
Clinical choices in managing LDL-c: Where do novel therapies fit in?
0.75 credits 4 episodesProf. Kausik Ray, MBChB, MD, MPhil
Julia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Ulrich Laufs, MD, PhD
- MinuteCE®
Understanding the role of triglycerides in the assessment of residual risk
0.50 program creditsProf. Alberto Zambon MD, PhD, FAHA